Menu
Study at Cambridge
About the University
Research at Cambridge
Login
Search for:
Cambridge Neuroscience
About
Cambridge Neuroscience
Our Vision
Research Themes
History
Giving to Cambridge Neuroscience
Governance
Joining Cambridge Neuroscience
Equality, Diversity, Inclusion and Wellbeing
Research & Collaboration
Research Themes
Neurons, Circuits and Networks
Adaptive Brain Computations
Lifelong Brain Development and Brain Ageing
The Social Brain
Brains and Machines
Beyond the Neuron
Training
Equipment & Resources
Finding a Collaborator
Open Science and Reproducibility
Multimedia Resources
Awards & External Networks
Directory
Principal investigators
Schools
Departments
Institutes
Popular Keywords
News, Events & Seminars
Overview
Seminars
Latest News
News Archive
Latest Event News
Event News Archive
CamNeuro events
CamNeuro events archive
Funding
Overview
Open calls
Funding events
Funding support
Research Professional
External funders
Early Career Researchers
Overview
CamBRAIN
PostDoc Neuroscience Network (PNN)
Postgraduate Training
Postgraduate Training Portal
Programmes
Search for a Project
Submit a Project
MPhil in Basic and Translational Neuroscience
Information
Information for
Prospective students
Current students
Researchers
Interns
Job applicants
Vacancies
New arrivals
Media enquiries
Patients and family members
Volunteers
Prospective donors
Finding a Collaborator
Engagement
Overview
Public
Policy
Commercial
Translational
Social Media
Contact
Visual hallucinations predict increased benefits from rivastigmine in Parkinson’s disease dementia.
Abstract:
© 2023 University of Cambridge
